⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Cefdinir

سفدینیر

⚠ Unverified

🦠 Antiinfectives For Systemic UseThird-generation cephalosporin

🤰 Pregnancy:Use with caution 🤱 Breastfeeding:Use with caution 👶 Children:Use with caution 👴 Older adults:Use with caution 🇮🇷 Not found in Iran list ⛔ 2 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA210534 ATC J01DD15

Market / country: 🇺🇸 USA

Omnicef (US)

🧮 Dose calculator

Disease / regimen

Acute otitis media · Regimen source: FDA Cefdinir susp · Dosage and Administration

Formulation

Age *

Weight (kg) *

Enter age and weight.

🛡️ Safety & information

Contraindications

⛔ Allergy to cephalosporins. FDA Cefdinir susp · Contraindications
⛔ Not established under 6 months. FDA Cefdinir susp · Pediatric Use

Renal adjustment

• eGFR < 30: CrCl <30: 7 mg/kg (up to 300 mg) once daily. FDA Cefdinir susp · Dosage and Administration

Formulations

125 mg/5 mL suspension — suspension 🇺🇸 USA FDA Cefdinir susp · Dosage and Administration, Pediatric Dosage Chart
250 mg/5 mL suspension — suspension 🇺🇸 USA FDA Cefdinir susp · Dosage and Administration, Pediatric Dosage Chart

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Cefdinir susp · PREGNANCY
“Teratogenic Effects Pregnancy Category B Cefdinir was not teratogenic in rats at oral doses up to 1000 mg/kg/day (70 times the human dose based on mg/kg/day, 11 times based on mg/m 2 /day) or in rabbits at oral doses up to 10 mg/kg/day (0.7 times the human dose based on mg/kg/day, 0.23 times based on mg/m 2 /day).”
🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Cefdinir susp · NURSING MOTHERS
“Following administration of single 600 mg doses, cefdinir was not detected in human breast milk”
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Cefdinir susp · PEDIATRIC USE
“Safety and efficacy in neonates and infants less than 6 months of age have not been established.”
👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Cefdinir susp · GERIATRIC USE
“Efficacy is comparable in geriatric patients and younger adults.”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)ANDA210534
DailyMed (FDA label)FDA Cefdinir susp
MedlinePlus (NIH)Cefdinir
WHO ATC/DDDJ01DD15
Darooyab (Iran)Cefdinir

🇮🇷 Not found in Iran list Darooyab · G-321/Cefdinir

Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Cefdinir susp · Dosage and Administration, Pediatric Dosage Chart FDA Cefdinir susp · Dosage and Administration FDA Cefdinir susp · Contraindications FDA Cefdinir susp · Pediatric Use FDA Cefdinir susp · PREGNANCY FDA Cefdinir susp · NURSING MOTHERS FDA Cefdinir susp · PEDIATRIC USE FDA Cefdinir susp · GERIATRIC USE FDA Cefdinir susp · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-321/Cefdinir
Clinical review⚠ Unverified